Three from MIT elected to the National Academy of Sciences for 2022
Faculty members Angela Belcher, Pablo Jarillo-Herrero, and Ronitt Rubinfeld elected by peers for outstanding contributions to research.
Faculty members Angela Belcher, Pablo Jarillo-Herrero, and Ronitt Rubinfeld elected by peers for outstanding contributions to research.
The 2nd Annual Research Slam featured three-minute talks on cutting-edge research from across MIT in an engaging public showcase and competition.
MIT biological engineers have developed a simple way to identify B or T cells that interact with viral or bacterial proteins.
Postdoc Digbijay Mahat became a cancer researcher to improve health care in Nepal, but the Covid-19 pandemic exposed additional resource disparities.
The protein subunit vaccine, which can be manufactured using engineered yeast, has shown promise in preclinical studies.
MIT senior Daniel Zhang aims to provide hope for young patients and support to young students.
A new analysis offers guidance on the size of nanoparticles that could be most effective at stopping internal bleeding.
Departments of Biology and Brain and Cognitive Sciences welcome new professors.
The technique can help predict a cell’s path over time, such as what type of cell it will become.
A computational study shows that dozens of mutations help the virus’ spike protein evade antibodies that target SARS-CoV-2.
A pill that releases RNA in the stomach could offer a new way to administer vaccines, or to deliver therapies for gastrointestinal disease.
The targeted approach eliminated tumors in mice, with minimal side effects.
The clinically-trained cell biologist exploits the liver’s unique capacities in search of new medical applications.
Study results also show that pancreatic tumor cells can be forced into a more susceptible state by changing their environment.
The potent new adjuvant could be used to help make vaccines against HIV and other infectious diseases.